Stockscreener 앱 받기
3.18
0.63%
-0.02
시간 외 거래:
3.10
-0.08
-2.52%
전일 마감가:
$3.20
열려 있는:
$3.2
하루 거래량:
24,088
Relative Volume:
0.27
시가총액:
$212.06M
수익:
$64.49M
순이익/손실:
$-71.40M
주가수익비율:
-2.9174
EPS:
-1.09
순현금흐름:
$-52.00M
1주 성능:
+0.63%
1개월 성능:
-10.67%
6개월 성능:
-12.88%
1년 성능:
-5.22%
1일 변동 폭
$3.1101
$3.23
1주일 범위
$2.92
$3.56
52주 변동 폭
$2.58
$4.92
Sophia Genetics Sa Stock (SOPH) Company Profile
SOPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.18 | 210.37M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
Predicting SOPHiA GENETICS SA trend using moving averagesPrice Forecast Based on AI Analysis - Newser
SOPHiA GENETICS SA Recovery Gathers Momentum on Chart SignalsAI Forecast for Trending Stocks Indicates Upside - beatles.ru
How to recover losses in SOPHiA GENETICS SA stockEquity Market Return Forecast Model Update - Newser
Advanced analytics toolkit walkthrough for SOPHiA GENETICS SAPre-Market Stock Movement Summary and Review - Newser
Using Ichimoku Cloud for SOPHiA GENETICS SA technicalsFree Trade Setups With Clear Risk Limits - Newser
Using Bollinger Bands to evaluate SOPHiA GENETICS SALow Risk Trade Timing with Analysis Metrics - Newser
Intraday pattern recognizer results for SOPHiA GENETICS SAFree AI Forecast for Trending Stocks - Newser
Why SOPHiA GENETICS SA stock attracts strong analyst attentionRisk Balanced Picks for Safer Trading - Newser
Is SOPHiA GENETICS SA stock bottoming outShort-Term Sector Movement Forecast Generator - Newser
Forecasting SOPHiA GENETICS SA price range with options dataValue Investing Checklist with Entry Signals - Newser
Analysts Are Updating Their SOPHiA GENETICS SA (NASDAQ:SOPH) Estimates After Its Second-Quarter Results - simplywall.st
Automated trading signals detected on SOPHiA GENETICS SAMarket Correction Proof Stock Screening Analysis - Newser
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q2 2025 Earnings Call Transcript - Insider Monkey
Visual trend scoring systems applied to SOPHiA GENETICS SAFree Entry Zone Strategy for Consistent Profit - Newser
SOPHiA GENETICS SA: Positive Earnings Call Highlights - TipRanks
Sophia Genetics SA (SOPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook - MSN
SOPHiA GENETICS Reports Strong Q2 2025 Growth - TipRanks
Will SOPHiA GENETICS SA price bounce be sustainableBuy Zone Strategy with Pattern Recognition - Newser
Sophia Genetics stock price target raised to $6 at BTIG on growth outlook - Investing.com Nigeria
Sophia Genetics stock price target raised to $6 at BTIG on growth outlook By Investing.com - Investing.com South Africa
Transcript : SOPHiA GENETICS SA, Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
SOPHiA GENETICS SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 123.8% - Defense World
Sophia Genetics SA reports results for the quarter ended June 30Earnings Summary - TradingView
SOPHiA GENETICS Reports Financial Results for Mid-2025 - TipRanks
SOPHiA GENETICS Reports Second Quarter 2025 Results - PR Newswire
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes - PR Newswire
What candlestick patterns are forming on SOPHiA GENETICS SAMomentum Entry Alerts with Risk Control - Newser
SOPHiA GENETICS SA Earnings Report Breakdown: What Investors Should KnowPredictive AI Signals for Short-Term Trading - Newser
Sophia Genetics SA (SOPH) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
When is the best time to exit SOPHiA GENETICS SAInsider Strategy for High Conviction Picks - Newser
Is SOPHiA GENETICS SA a good long term investmentAchieve breakthrough profits with expert advice - Jammu Links News
What analysts say about SOPHiA GENETICS SA stockInvest confidently with professional market insights - Jammu Links News
What institutional investors are buying SOPHiA GENETICS SA stockAchieve consistent profits with smart trading - Jammu Links News
SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday - Defense World
Should I hold or sell SOPHiA GENETICS SA stock in 2025Stay informed with expert market forecasts - Jammu Links News
Is it the right time to buy SOPHiA GENETICS SA stockCapitalize on market shifts before others do - Jammu Links News
Is SOPHiA GENETICS SA a growth stock or a value stockMassive stock growth - Jammu Links News
What are SOPHiA GENETICS SA company’s key revenue driversCapitalize on strong market momentum - Jammu Links News
How does SOPHiA GENETICS SA compare to its industry peersAchieve rapid capital gains with smart investing - Jammu Links News
What are the latest earnings results for SOPHiA GENETICS SAInvest in stocks with strong fundamentals - Jammu Links News
What makes SOPHiA GENETICS SA stock price move sharplyMaximize returns with timely market signals - Jammu Links News
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.97%
6.08%
자본화:
|
볼륨(24시간):